Drug interactions
Buprenorphine subdermal implant + Telavancin
Severity: Minor
Buprenorphine subdermal implant and Telavancin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Telavancin may modestly prolong the QT interval, and buprenorphine has a QT effect that is mainly dose related. The implant gives low, steady exposure, so the additive risk is small but not zero in patients with other predisposing factors.
What this interaction means in plain words
Buprenorphine subdermal implant and Telavancin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive pharmacodynamic QT prolongation, with a limited contribution from the low steady-state buprenorphine exposure.
What to do
No routine action is needed in low-risk patients. Check an ECG and electrolytes if the patient has congenital long QT, electrolyte disturbance or other QT-prolonging drugs.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Telavancin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Telavancin
- Telavancin + Thioridazine Contraindicated
- Adagrasib + Telavancin Major
- Amiodarone + Telavancin Major
- Amisulpride + Telavancin Major
- Anagrelide + Telavancin Major
- Arsenic trioxide + Telavancin Major
Frequently asked questions
Can I take Buprenorphine subdermal implant with Telavancin?
MediHelp rates the interaction as minor. Buprenorphine subdermal implant and Telavancin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Telavancin may modestly prolong the QT interval, and buprenorphine has a QT effect that is mainly dose related. The implant gives low, steady exposure, so the additive risk is small but not zero in patients with other predisposing factors.
How serious is the interaction between Buprenorphine subdermal implant and Telavancin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action is needed in low-risk patients. Check an ECG and electrolytes if the patient has congenital long QT, electrolyte disturbance or other QT-prolonging drugs.
What other medicines interact with Telavancin?
MediHelp also lists interactions of Telavancin with, for example, Thioridazine, Adagrasib, Amiodarone. The full list is on the Telavancin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
